Written by Jamie Day
The Bayer Group has announced a $110 million collaboration with Arvinas, a US biopharmaceutical company based in New Haven, Connecticut, to develop novel products for the crop protection and human healthcare sectors. The new life science research partnership will leverage the potential of Arvinas’ novel proteolysis-targeting chimera (PROTAC) technology with Bayer’s experience in health and […]
The post Bayer JV to develop biopesticides appeared first on AgriTrade News.
Continue reading more content from AgriTrade News...
If you are enjoying what you read then why not considering subscribing:
